IBA Business Update – First Quarter 2024
IBA Business Update – First Quarter 2024
Louvain-la-Neuve, Belgium, May 23rd, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces its business update for the first quarter ending 31 March 2024.
Group Overview
- Good Group order intake at end of March, driven by continued growth in Other Accelerators, with typical strong second half weighting expected
- Group backlog remains at a high of EUR 1.4 billion
- EUR 30.1 million net cash position, decreasing as a result of a planned procurement of inventory, related to backlog conversion and among others the ten-room Proteus®ONE1 contract in Spain
- B Corp certification renewed with a significantly improved score of 114 points (2021: 90 points), placing the Group among the top 10% of those certified globally
Olivier Legrain, Chief Executive Officer of IBA commented: “IBA has had a solid start to the year with a core focus on backlog execution and unlocking future growth potential. We continue to invest for growth and to maintain our leading edge across all of our businesses. We do expect a typical second half weighting both in terms of backlog conversion and order intake, supported by the opportunities in our pipeline.”